Cancer Research UK partners with ORIC Pharmaceuticals to bring first-in-class CIP2A-targeted therapy into clinical trials
Cancer Research UK have signed an agreement with ORIC Pharmaceuticals, Inc. to advance ORIC-259, a potential first-in-class CIP2A-targeted therapy, into clinical development. Under the agreement, Cancer Research UK’s Centre for […]
Clearing ‘immune fog’ could stop lung cancer years before diagnosis
Scientists funded by Cancer Research UK have discovered a “rising fog” that may cloud the immune system’s ability to detect tumours, potentially helping lung cancer develop years before diagnosis. The […]
Cancer Research Horizons partners with Nexomic to advance AI-powered precision oncology
Cancer Research Horizons, the innovation engine of Cancer Research UK, has announced a partnership with Nexomic, a precision oncology TechBio company developing AI-powered tools to improve cancer care. The agreement […]
Immune ‘blind spot’ in cancer focus of new study
A new project funded by Cancer Research UK will explore why half of patients with a silent blood condition called smouldering myeloma will go on to develop an incurable cancer. […]
Cancer Research UK and partners announce new global phase 2 trial in rare adrenal gland cancer
Cancer Research UK, Cytovation and the Norwegian Cancer Society have announced a new multi-national Phase 2 clinical trial (CLARITY; ISRCTN15479264) for people with advanced adrenocortical carcinoma (ACC), a rare and […]
World leading research receives cash boost in Manchester
Cancer Research UK will invest an additional £6m each year into world-leading research in Manchester and create up to an additional 100 new jobs. The charity’s annual investment into the Cancer Research […]
Hundreds of cancer patients to benefit from improved access to genetic testing
Cancer Research UK has announced that from now it is making hundreds of specialised blood tests available to people affected by cancer across the UK. As a co-funder of the […]
UCB, Cancer Research UK and Cancer Research Horizons announce new strategic alliance to accelerate development of novel cancer therapies
UCB, a global biopharmaceutical company, has announced a new multi‑project strategic alliance with Cancer Research UK and its innovation arm, Cancer Research Horizons. The collaboration will unite Cancer Research UK’s […]
New £1m clinical trial launches to improve quality of life for people with blood cancer
Dr Kevin Rouault-Pierre and team at Barts Cancer Institute, Queen Mary University of London, have been awarded funding to launch a new clinical trial aiming to improve quality of life […]
First-of-its-kind international trial launches to harness the immune system against childhood cancers
The first person has been enrolled in a new clinical trial taking place in the UK and the US, offering a specific group of up to 60 children with cancer […]
